Using data from a prospective study of Korean patients with depressive disorders receiving stepwise antidepressant treatment, we investigated the effects of the baseline serum TNF-α (sTNF-α) level on antidepressant treatment outcomes including 12-week and 12-month remission and 24-month relapse. The gene discussed is TNF; the disease is depressive disorder.